本研究旨在将基于后设认知的 ConquerFear-HK 改编为互联网为本的自我管理干预，即 eConquerFear-HK，并通过随机对照试验评估其可行性、实用性及对本地华人癌症康复者亚临床癌症复发恐惧的潜在成效。
适应症：Cancer、Psychooncology、Fear of Cancer Recurrence
入组条件
纳入标准
- Cantonese- or Mandarin-speaking Chinese cancer survivors
- recently diagnosed with potentially curable (stage 0 to III) colorectal or breast cancer
- had recently completed surgery as primary treatment
- have completed hospital-based adjuvant treatments (including radiotherapy and chemotherapy) within the past six months
- scored 13 to 21 on the fear of cancer recurrence-short form will be recruited.
排除标准
- non-Chinese ethnicity
- metastatic cancer
- with current diagnosis of depression or psychosis or are currently receiving psychological treatments
- language or intellectual difficulties that prevent them from understanding the intervention content
- having limited or no Internet access.
入组条件维持 ClinicalTrials.gov 原始英文登记资料，实际入组资格以研究团队的正式评估与受试者知情同意书为准。资料来源：ClinicalTrials.gov，每两周自动更新，最后同步：2026年10月8日。